Profile data is unavailable for this security.
About the company
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.
- Revenue in JPY (TTM)610.12m
- Net income in JPY-1.29bn
- Incorporated2001
- Employees60.00
- LocationOncoTherapy Science Inc1-2, Higashida-cho, Kawasaki-kuKAWASAKI-SHI 210-0005JapanJPN
- Phone+81 442016429
- Fax+81 442016473
- Websitehttps://www.oncotherapy.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PhoenixBio Co Ltd | 1.79bn | 113.89m | 2.11bn | 65.00 | 26.35 | 1.19 | 15.22 | 1.18 | 19.88 | 19.88 | 401.02 | 440.43 | 0.6625 | 1.52 | 7.19 | 27,575,230.00 | 4.21 | -7.00 | 6.09 | -8.77 | 67.48 | 65.55 | 6.35 | -12.08 | 4.19 | -- | 0.2199 | -- | 60.33 | 18.67 | 227.16 | -- | 14.18 | -- |
Modalis Therapeutics Corp | 0.00 | -2.32bn | 2.43bn | 37.00 | -- | 2.23 | -- | -- | -72.46 | -72.46 | 0.00 | 29.59 | 0.00 | -- | -- | 0.00 | -103.95 | -29.19 | -112.89 | -30.02 | -- | -- | -- | -597.35 | 9.75 | -- | 0.2638 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
Muromachi Chemicals Inc | 6.12bn | 216.69m | 3.00bn | 205.00 | 13.71 | 1.39 | 8.54 | 0.4904 | 53.45 | 53.45 | 1,503.34 | 527.87 | 1.20 | 3.83 | 3.75 | 29,862,370.00 | 4.23 | -- | 6.84 | -- | 28.31 | -- | 3.54 | -- | 1.45 | 26.20 | 0.4483 | -- | 10.74 | -- | -43.83 | -- | -- | -- |
Ribomic Inc | 62.64m | -979.09m | 3.07bn | 25.00 | -- | 0.8367 | -- | 48.96 | -27.45 | -27.45 | 1.76 | 100.39 | 0.0144 | -- | 1.22 | 2,505,440.00 | -22.56 | -32.10 | -24.05 | -33.30 | -- | -- | -1,563.14 | -1,688.50 | 18.53 | -- | 0.00 | -- | -18.47 | 0.3809 | 1.88 | -- | 10.04 | -- |
Atect Corp | 3.18bn | -244.35m | 3.17bn | 96.00 | -- | 1.79 | 9.16 | 0.9975 | -55.27 | -55.27 | 718.38 | 398.84 | 0.5895 | 3.30 | 6.85 | -- | -4.54 | 0.7132 | -6.41 | 0.9718 | 43.40 | 47.04 | -7.69 | 1.32 | 0.6992 | -- | 0.5902 | 84.76 | 7.23 | 1.45 | -253.71 | -- | -23.49 | 0.00 |
OncoTherapy Science, Inc. | 610.12m | -1.29bn | 3.35bn | 60.00 | -- | 9.23 | -- | 5.50 | -6.09 | -6.09 | 2.87 | 1.62 | 0.513 | 9.08 | 7.69 | -- | -108.31 | -55.67 | -182.73 | -63.82 | -29.13 | -1.49 | -211.13 | -247.47 | 2.07 | -189.93 | 0.232 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
D.Western Therapeutics Institute Inc | 443.18m | -1.04bn | 3.55bn | 21.00 | -- | 3.69 | -- | 8.01 | -32.29 | -32.29 | 13.84 | 29.84 | 0.1784 | 0.472 | 3.10 | 21,103,950.00 | -42.16 | -13.06 | -45.11 | -14.36 | 91.32 | 94.29 | -236.36 | -72.51 | 11.65 | -- | 0.509 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
Kringle Pharma Inc | 77.93m | -904.81m | 3.77bn | 13.00 | -- | 1.61 | -- | 48.41 | -159.92 | -159.92 | 13.58 | 356.64 | 0.027 | -- | 2.80 | 5,994,308.00 | -31.29 | -19.00 | -33.20 | -20.23 | -- | -- | -1,161.12 | -156.51 | 12.85 | -- | -- | -- | -82.33 | -- | -157.41 | -- | -- | -- |
Kubota Pharmaceutical Holdings Co Ltd | 39.74m | -1.39bn | 3.83bn | 12.00 | -- | 1.64 | -- | 96.32 | -24.82 | -24.82 | 0.711 | 41.58 | 0.0118 | 0.3815 | 26.89 | 3,312,000.00 | -41.32 | -36.51 | -45.53 | -39.47 | 72.88 | -- | -3,492.38 | -13,528.87 | 8.97 | -- | 0.0555 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
Perseus Proteomics Inc | 96.22m | -1.12bn | 3.83bn | 24.00 | -- | 2.37 | -- | 39.84 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.90bn | 57.00 | 13.80 | 2.21 | 10.70 | 2.95 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
FunPep Co Ltd | 530.00k | -933.42m | 4.14bn | 15.00 | -- | 1.67 | -- | 7,802.64 | -40.11 | -40.11 | 0.0225 | 94.97 | 0.0002 | -- | -- | 35,333.33 | -34.04 | -27.10 | -35.68 | -28.75 | -- | -- | -176,116.20 | -815.82 | 25.95 | -1,765.73 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
BrightPath Biotherapeutics Co Ltd | 72.00k | -1.17bn | 4.19bn | 32.00 | -- | 4.26 | -- | 58,132.45 | -18.30 | -18.30 | 0.0011 | 13.84 | 0.00005 | -- | 2.36 | -- | -79.69 | -51.56 | -87.69 | -54.32 | 75.00 | 68.63 | -1,622,336.00 | -22,321.82 | -- | -435.39 | 0.1031 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
Renascience Inc | 194.17m | -258.34m | 4.59bn | 3.00 | -- | 2.86 | -- | 23.63 | -20.32 | -20.32 | 15.27 | 126.40 | 0.089 | -- | -- | -- | -11.84 | -- | -12.49 | -- | 85.31 | -- | -133.05 | -- | -- | -- | 0.1814 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.63bn | 60.00 | -- | 4.21 | -- | 5.87 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
Delta-Fly Pharma Inc | 0.00 | -1.26bn | 4.65bn | 11.00 | -- | 2.75 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to OncoTherapy Science Inc's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
Long Corridor Asset Management Ltd.as of 07 May 2024 | 2.00m | 0.92% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.